• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].

作者信息

Domaradzka-Woźniak A, Wojtacki J, Dziewulska-Bokiniec A

机构信息

Miejskiej Przychodni Onkologicznej, Gdańsku.

出版信息

Przegl Lek. 1994;51(5):203-5.

PMID:7938648
Abstract

The antiemetic efficacy of dexamethasone (Dexaven) was examined in patients with breast cancer during chemotherapy CMF (cyclophosphamide, methotrexate and 5-fluorouracil) in comparison with patients treated identically but without dexamethasone. Comparison of the revealed statistically significant lower nausea incidence (p < 0.025) and lower vomiting incidence (p < 0.025) in the group of patients receiving dexamethasone. The results confirm value of dexamethasone as an effective and safe antiemetic agent using during chemotherapy CMF.

摘要

相似文献

1
[Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].
Przegl Lek. 1994;51(5):203-5.
2
Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil.在乳腺癌环磷酰胺、甲氨蝶呤和氟尿嘧啶化疗中，昂丹司琼与地塞米松和甲氧氯普胺作为止吐药的比较。
N Engl J Med. 1993 Apr 15;328(15):1081-4. doi: 10.1056/NEJM199304153281503.
3
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.阿瑞匹坦预防中度致吐性化疗后乳腺癌患者化疗引起的恶心和呕吐的疗效及耐受性
J Clin Oncol. 2005 Apr 20;23(12):2822-30. doi: 10.1200/JCO.2005.09.050.
4
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma.
Cancer Treat Rep. 1982 Aug;66(8):1601-4.
5
[Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].盐酸雷莫司琼在乳腺癌CMF或CEF方案化疗中对恶心呕吐的防治作用
Gan To Kagaku Ryoho. 1999 Jul;26(8):1163-70.
6
Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.在接受中度致吐性化疗的乳腺癌患者中，短暂（30秒推注）静脉注射格拉司琼与标准（15分钟）静脉注射昂丹司琼的安全性和止吐疗效相当。
Cancer J Sci Am. 1998 Jan-Feb;4(1):52-8.
7
Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.输注帕洛诺司琼加地塞米松预防化疗引起的恶心和呕吐。
J Support Oncol. 2006 Oct;4(9):467-71.
8
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.阿瑞匹坦、昂丹司琼和地塞米松用于接受中度致吐性化疗的中国乳腺癌患者化疗引起的恶心和呕吐的随机研究。
Breast Cancer Res Treat. 2009 Feb;113(3):529-35. doi: 10.1007/s10549-008-9957-9. Epub 2008 Mar 10.
9
Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.昂丹司琼与地塞米松对比标准联合止吐疗法：一项预防环磷酰胺-阿霉素化疗引起的急性和迟发性呕吐以及在后续疗程维持止吐效果的随机试验。
Am J Clin Oncol. 1994 Dec;17(6):522-6.
10
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study.口服昂丹司琼预防乳腺癌女性患者使用环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）引起的恶心和呕吐。一项前瞻性、随机、双盲、安慰剂对照研究的结果。
Ann Oncol. 1993 Jun;4(6):475-9. doi: 10.1093/oxfordjournals.annonc.a058556.